QTTB Q32 Bio Inc.
Q32 Bio Inc. (QTTB) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $163.0K.
Where they traded
Last open-market purchase: May 28, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Morrison Jodie Pope | CEO | Sell | 9,845 | $16.56 | $163.0K | 343,259 −2.8% of holding | |
| Kalowski Lee | CFO and President | Sell | 3,972 | $16.56 | $65.8K | 138,471 −2.8% of holding | |
| Violette Shelia M. | Chief Scientific Officer | Sell | 2,798 | $16.56 | $46.3K | 127,771 −2.1% of holding | |
| 2 fills | Buy | 1,875,000 | $8.00 | $15.0M | 3,502,987 | ||
| Xu Diyong 2 fills | Director | Buy | 1,875,000 | $8.00 | $15.0M | 3,502,987 | |
| Morrison Jodie Pope | CEO | Sell | 9,896 | $4.51 | $44.7K | 89,104 −10% of holding | |
| Kalowski Lee | CFO and President | Sell | 3,995 | $4.51 | $18.0K | 35,943 −10% of holding | |
| Violette Shelia M. | Chief Scientific Officer | Sell | 2,815 | $4.51 | $12.7K | 55,569 −4.8% of holding | |
| Morrison Jodie Pope | CEO | Sell | 22,506 | $3.46 | $77.9K | 99,000 −18.5% of holding | |
| Kalowski Lee | CFO and President | Sell | 9,072 | $3.46 | $31.4K | 39,938 −18.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.